JPRN-jRCTs072200039
Active, not recruiting
Phase 2
Evaluation of safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex - Cryo-tsc Study
Eto Masatoshi0 sites15 target enrollmentOctober 1, 2020
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- renal angiomyolipoma associated with tuberous sclerosis
- Sponsor
- Eto Masatoshi
- Enrollment
- 15
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.A patient over 16 years old at the time of obtaining consent
- •2\.A patient with a definitive diagnosis of tuberous sclerosis according to the modified Gomez criteria or the TSC Clinical Consensus Guideline for Diagnosis 2012 at the time of registration
- •3\.A patient with an independent AML on imaging within 4months before enrollment measuring greater than 1 cm and less than 4 cm in long axis as the treatment target, regardless of prsence or absence of mTOR inhibitor treatment
- •4\.Informed consent has been obtained from one of the following:
- •1\)The patient only (if the patient is over 20 years old and can fully understand the explanation)
- •2\)The patient and his / her substitute (parent, guardian, etc.) (if the patient is under 20 years old and can fully understand the explanation)
- •3\)Legal guardian only (if the patient is judged to lack the ability to make a decision regarding the conduct of the study)
Exclusion Criteria
- •1\.A patient who cannot interrupt mTOR inhibitor treatment
- •2\.A patient who cannot keep still during cryotherapy
- •3\.A patient with platelets less than 6X10^4/uL(within 28 days before registration)
- •4\.A patient with a history of serious allergies to contrast agents and / or embolic substances
- •5\.A patient with infection requiring systemic treatment
- •6\.A patient with malignant tumor
- •7\.A woman who is pregnant, possibly pregnant or within 28 days after delivery
- •8\.A patient who has a mental illness or psychiatric disorder that interferes with daily life, such that participation in the study is considered difficult
- •9\.A patient with uncontrolled hypertension
- •10\.A patient who is otherwise assessed as inappropriate by the doctor in charge
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Radioation therapy followed by cryoablation for malignant lung tumorsJPRN-UMIN000037215Kashiwa Kousei General Hospital, Thoracic Surgery200
Recruiting
Not Applicable
Study of the ClariFix Cryoablation Device in Patients with Chronic Rhinitis - New ZealandChronic rhinitisRespiratory - Other respiratory disorders / diseasesACTRN12614000468628Arrinex, Inc.30
Not yet recruiting
Not Applicable
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30
Recruiting
Not Applicable
Efficacy and safety of different modalities in the treatment of seborrheic keratosisseborrheic keratosis.Seborrheic keratosisIRCT20141228020468N5Shahid Beheshti University of Medical Sciences32
Completed
Not Applicable
Safety cofirmatory study for Percutaneous cryoablation of vascular malformationsvascular malformationJPRN-UMIN000012194Okayama University Hospital9